Is 500mg twice daily (BID) of cefuroxime (Cefuroxime) an appropriate dose for a 13-year-old patient weighing 142 pounds (64 kg)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefuroxime Dosing for a 13-Year-Old Weighing 142 lbs (64 kg)

Yes, 500mg BID (twice daily) of cefuroxime is an appropriate dose for a 13-year-old weighing 142 lbs (64 kg). 1

Dosing Rationale

  • For children with Lyme disease, the recommended dose of cefuroxime axetil is 30 mg/kg/day in 2 divided doses, with a maximum of 500 mg per dose 1
  • For a 13-year-old weighing 64 kg, this would calculate to approximately 960 mg/day total, or 480 mg twice daily, which rounds to the standard 500 mg BID dosing 1
  • For children with respiratory tract infections, the British Thoracic Society guidelines recommend 250 mg BID for children 2-12 years and 500 mg BID for those over 12 years 1
  • Since this patient is 13 years old and weighs more than 40 kg (88 lbs), the adult dosing of 500 mg twice daily is appropriate 1, 2

Weight-Based Considerations

  • The patient weighs 142 lbs (64 kg), which exceeds the 40 kg (88 lb) threshold often used for transitioning to adult dosing 1
  • For children >40 kg in weight, adult dosing parameters are typically applied 3
  • The standard adult dose of cefuroxime axetil for most infections is 250-500 mg twice daily 2

Infection-Specific Dosing

  • For respiratory tract infections: 500 mg BID is appropriate for more severe infections 2
  • For skin and soft tissue infections: 250-500 mg BID is the standard dose 2
  • For urinary tract infections: 250 mg BID is typically sufficient 4
  • For Lyme disease: 500 mg BID is recommended (with maximum 500 mg per dose) 1

Safety Considerations

  • Cefuroxime axetil is generally well tolerated in pediatric patients 5
  • Most common adverse effects are mild gastrointestinal disturbances (diarrhea, nausea, vomiting) 2
  • No dosage adjustment is needed based on age alone for patients over 12 years with normal renal function 3
  • The 500 mg BID dosing has been shown to be safe and effective in adolescents 5

Important Clinical Considerations

  • Cefuroxime should be administered with food to improve gastrointestinal tolerability and increase absorption 2
  • The duration of therapy typically ranges from 5-10 days depending on the type and severity of infection 5
  • For most common infections, a 7-day course is sufficient 2
  • For Lyme disease, a longer course (14-21 days) may be necessary 1

Conclusion

Based on the patient's age (13 years) and weight (142 lbs/64 kg), the 500 mg BID dosing of cefuroxime is appropriate and aligns with established guidelines for adolescents. This dose provides adequate coverage for most common infections while maintaining a favorable safety profile 1, 2, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cefuroxime axetil.

International journal of antimicrobial agents, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.